During the past decade, TLC Laser Eye Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "TLC Laser Eye Center" are "Keratoconus" (3 trials), "Degeneration" (2 trials), "Ectasia" (2 trials), "Fruste Keratoconus" (1 trials) and "Risk of Ectasia" (1 trials). Many other conditions were trialed in "TLC Laser Eye Center" in a lesser frequency.

Most popular intervention types in "TLC Laser Eye Center" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Steroid (FML, Pred Forte, Flarex, etc.)" (2 trials), "Ciprofloxicin or Vigamox or other." (1 trials), "Ciprofloxicine or Vigamox or other." (1 trials), "Corneal Cross-Linking" (1 trials) and "Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)" (1 trials). Other intervention names were less common.

The vast majority of trials in "TLC Laser Eye Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "TLC Laser Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in TLC Laser Eye Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in TLC Laser Eye Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".